From: XIAP is not required for human tumor cell survival in the absence of an exogenous death signal
Drug | Cell line | EC50 (μM) | |||
---|---|---|---|---|---|
 |  | Untreated | Electroporated | Control siRNA | XIAP siRNA |
Bortezomib | HCT-116 | 0.0075 | 0.0050 | 0.0047 | 0.0045 |
Doxorubicin | HCT-116 | 0.29 | 0.13 | 0.16 | 0.11 |
Etoposide | HCT-116 | 34.11 | 12.99 | 10.62 | 8.90 |
Paclitaxel | HCT-116 | 0.0083 | 0.0040 | 0.0024 | 0.0031 |
SAHA | HCT-116 | 2.014 | 0.98 | 0.67 | 0.51 |
Vincristine | HCT-116 | 0.015 | 0.0067 | 0.0035 | 0.0045 |
Bortezomib | SW-620 | 0.0036 | 0.0025 | 0.0025 | 0.0017 |
Doxorubicin | SW-620 | 0.79 | 0.657 | 0.48 | 0.43 |
Etoposide | SW-620 | 31.79 | 25.55 | 33.68 | 22.70 |
Paclitaxel | SW-620 | 0.017 | 0.0067 | 0.0086 | 0.0064 |
SAHA | SW-620 | 1.69 | 0.98 | 1.29 | 0.97 |
Vincristine | SW-620 | 0.035 | 0.013 | 0.031 | 0.0095 |
Bortezomib | PC-3 | 0.01 | 0.0063 | 0.0037 | 0.0041 |
Doxorubicin | PC-3 | 0.15 | 0.073 | 0.038 | 0.038 |
Etoposide | PC-3 | 41.96 | 16.58 | 26.13 | 16.76 |
Paclitaxel | PC-3 | 0.0028 | 0.00090 | 0.00067 | 0.00037 |
SAHA | PC-3 | 1.762 | 0.72 | 0.068 | 0.53 |
Vincristine | PC-3 | 0.0025 | 0.0016 | 0.0016 | 0.0016 |